Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$60.27M
↑ 154% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
$-111.13M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $60.27M | +10.8% |
| 2024 | $54.40M | +135.0% |
| 2023 | $-155.56M | +13.3% |
| 2022 | $-179.50M | +20.8% |
| 2021 | $-226.73M | -86.8% |
| 2020 | $-121.40M | -30.4% |
| 2019 | $-93.10M | +54.5% |
| 2018 | $-204.59M | -21.1% |
| 2017 | $-168.98M | -121.9% |
| 2016 | $-76.15M | - |